Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 138Neoplasms 5Neoplasm Metastasis 4Prostate Adenocarcinoma 3Recurrence 2Osteoporosis 2Advanced Prostate Cancer 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Sarcopenia 1Radiation Injuries 1Primary Dysautonomias 1Patients With T1-4 Advanced Prostate Cancer 1PSA Level Greater Than Two 1Lymphatic Metastasis 1Kidney Diseases 1Hypertension 1Hot Flashes 1Hormone Sensitive Prostate Cancer 1Castration-resistant Prostate Cancer Patients with Oligometastases 1Castrate Sensitive Prostate Cancer 1Anemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 6Cyclophosphamide 6fludarabine phosphate 5Nivolumab 5Mycophenolic Acid 5Carboplatin 5Whole-Body Irradiation 4Radiotherapy 4Filgrastim 4Cyclosporine 4Gemcitabine 3Cisplatin 3Busulfan 3Antilymphocyte Serum 3cabozantinib 2cabazitaxel 2Voriconazole 2Thiotepa 2Therapeutics 2Standard of Care 2Sirolimus 2Polymerase Chain Reaction 2Mitomycin 2Methylprednisolone 2Methotrexate 2Melphalan 2Itraconazole 2Immunoglobulin G 2Goserelin 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Goserelin × Genitourinary × Clear all
NCT00439751 2016-07-12

ELAAT

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed
79 enrolled
Genitourinary

Prostatic Neoplasms, Recurrence

NCT01531205 2014-11-05

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled 6 charts
Genitourinary

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡